CCM FY 2014 Earnings Report — Concord Medical Services Holdings Limited Revenue & Financial Results | Market Cap Arena

Concord Medical Services Holdings LimitedCCM

FY 2014 Earnings

Reported April 27, 2015

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2014	Prior Q	FY 2013	QoQ Change	YoY Change
Revenue	$89M	—	$82M	—	7.8%
Op. Income	$27M	—	$23M	—	17.5%
Gross Margin	54.8%	—	61.3%	—	-6.6pp
Net Margin	20.5%	—	15.3%	—	5.3pp
EPS (Diluted)	$96.17	—	$73.13	—	31.5%
Free Cash Flow	$56M	—	$14M	—	284.3%

Revenue Flow

Item	Amount
REVENUE	$89M
Cost of Revenue	$40M
GROSS PROFIT	$49M
R&D Expenses	$0
Selling & Marketing	$14M
General & Administrative	$8M
SG&A Expenses	$22M
Other Expenses	$0
Operating Expenses	$22M
Cost & Expenses	$62M
OPERATING INCOME	$27M
Interest Income	$3M
Interest Expense	$8M
Other Income/Expenses	-$1M
INCOME BEFORE TAX	$26M
Income Tax Expense	$12M
Net Income from Continuing Ops	$14M
Net Income from Discontinued Ops	$4M
Other Adjustments	$0
NET INCOME	$18M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$14M
D&A	$29M
EBIT	$27M
EBITDA	$56M
EPS	$97
EPS Diluted	$96

Income Statement

Item	Amount
REVENUE	$89M
Cost of Revenue	$40M
GROSS PROFIT	$49M
R&D Expenses	$0
Selling & Marketing	$14M
General & Administrative	$8M
SG&A Expenses	$22M
Other Expenses	$0
Operating Expenses	$22M
Cost & Expenses	$62M
OPERATING INCOME	$27M
Interest Income	$3M
Interest Expense	$8M
Other Income/Expenses	-$1M
INCOME BEFORE TAX	$26M
Income Tax Expense	$12M
Net Income from Continuing Ops	$14M
Net Income from Discontinued Ops	$4M
Other Adjustments	$0
NET INCOME	$18M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$14M
D&A	$29M
EBIT	$27M
EBITDA	$56M
EPS	$97
EPS Diluted	$96

Cash Flow Statement

Item	Amount
Net Income	$18M
Depreciation & Amortization	$29M
Stock-Based Compensation	$1M
Deferred Income Tax	$0
Other Non-Cash Items	$13M
Change in Working Capital	$10M
OPERATING CASH FLOW	$72M
Capital Expenditure	-$16M
Acquisitions (Net)	$0
Purchases of Investments	$0
Sales/Maturities of Investments	$0
Other Investing Activities	$58M
NET CASH FROM INVESTING	$42M
Net Debt Issuance	$8M
Common Stock Repurchased	$0
Common Dividends Paid	$0
Other Financing Activities	-$27M
NET CASH FROM FINANCING	-$85M
FREE CASH FLOW	$56M
Net Change in Cash	$29M

Balance Sheet

Item	Amount
Cash & Equivalents	$70M
Short-Term Investments	$0
Net Receivables	$83M
Inventory	$436.1K
Other Current Assets	$84M
TOTAL CURRENT ASSETS	$214M
PP&E (Net)	$109M
Goodwill	$0
Intangible Assets	$16M
Long-Term Investments	$32M
Tax Assets	$3M
Other Non-Current Assets	$58M
TOTAL NON-CURRENT ASSETS	$218M
TOTAL ASSETS	$432M
Account Payables	$155.4K
Short-Term Debt	$83M
Deferred Revenue	$151.6K
Other Current Liabilities	$21M
TOTAL CURRENT LIABILITIES	$112M
Long-Term Debt	$49M
Deferred Revenue NC	$197.0K
Deferred Tax Liabilities	$7M
Other Non-Current Liabilities	$8M
TOTAL NON-CURRENT LIABILITIES	$57M
TOTAL LIABILITIES	$169M
Common Stock	$15.3K
Additional Paid-In Capital	$303M
Retained Earnings	-$38M
Treasury Stock	-$730
Accum. Other Comp. Income	-$3M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$263M
Minority Interest	$366.4K
TOTAL EQUITY	$263M
TOTAL LIABILITIES & EQUITY	$432M
Total Debt	$132M
Net Debt	$62M